CLASS II ONGOING Drug recall · Reported 10 Dec 2025 · FDA Enforcement Report

Phytonadione Injectable Emulsion, USP 10mg/mL recalled by Cipla

Cipla is recalling Phytonadione Injectable Emulsion, USP 10mg/mL, mL Single-Dose Vial/carton, distributed nationwide in the US. The recall was initiated on 31 Oct 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesBatch # PH0072404A, PH0082404A, Exp. Date December 31, 2025
NDC69097-708, 69097-709
Quantity recalled4,438 10x1mL cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0197-2026
FDA event ID
97909
Recalling firm
Cipla, Pithampur, District Dhar
Manufacturer
Cipla USA Inc.
Classification
Class II
Status
Ongoing
Recall initiated
31 Oct 2025
FDA classified
28 Nov 2025
Reported
10 Dec 2025
Type
Voluntary: Firm initiated
Reason category
Potency & Assay

Timeline

31 Oct 2025Recall initiated by company
28 Nov 2025Classified by FDA+28 days
10 Dec 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Stability Specifications: Observed OOS results: eg results for colour index

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097-708-31; Carton NDC 69097-708-96

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Failed Stability Specifications: Observed OOS results: eg results for colour index

Which lots are affected?

Batch # PH0072404A, PH0082404A, Exp. Date December 31, 2025

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Cipla

All 14
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIArformoterol Tartrate Inhalation Solution, 15 mcg/ Sterile Unit-Dose recalledArformoterol TartrateCiplaSterilityNationwide
DrugCLASS IIBudesonide Inhalation Suspension 0.25mg/, For Inhalation Only recalledBudesonideCiplaSterilityNationwide
DrugCLASS IIDifluprednate Ophthalmic Emulsion recalled by CIPLADifluprednateCiplaSterilityNationwide
DrugCLASS IIDifluprednate Ophthalmic Emulsion recalled by CIPLACiplaSterilityNationwide
DrugCLASS IIDifluprednate Ophthalmic Emulsion recalled by CIPLADifluprednateCiplaSterilityNationwide

Other Phytonadione recalls

All 8